Johanna Olweus
@jolweus
Group leader & Head of Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital; Professor, Inst. for Clin. Med., University of Oslo
ID: 901748071712923648
https://www.ous-research.no/olweus/ 27-08-2017 10:07:48
147 Tweet
496 Followers
93 Following
Fantastisk å være en del av MATCHMAKERS team og få et Cancer Grand Challenge Grant til Norden for første gang. Tusen takk til alle støttespillere! Kreftforeningen, Precision Immunotherapy Alliance Norges forskningsråd Oslounivsykehus UiO - Det medisinske fakultet @helsesorost
We are grateful to our excellent SAB for their valuable advice! And to Ron Germain for sharing his spectacular data with us in Oslo Norges forskningsråd UiO - Det medisinske fakultet Oslounivsykehus
Join us at #ImmunoOnco24 and follow the inspiring talk of Johanna Olweus Johanna Olweus @unioslo_medbibl! 🗓️Early bird registration till 18th of April vibconferences.be/events/recent-… CCB_VIB_KUL @VIBConferences
Happy to share that our great collaboration with Cinzia Cantacessi 🇪🇺🇮🇹🇦🇺🇬🇧 has led to a new research article on #nematode-derived #antimicrobial #peptides: csbj.org/article/S2001-… Thanks to James Rooney for his hard work during his PhD and for his exchange with us at DTU Bioengineering!
Great 1st session at the #CIMT2024 on Improving Immunity by leveraging Dendritic Cells (Stefani Spranger Koch Institute at MIT), rewiring microbiome (Marcel van den Brink City of Hope) and remodeling tumor vasculature (DimbergLab @UU_University) to enhance Cancer #Immunotherapy Cancer Immunotherapy 🩸🧬🦠
Insightful #CIMT2024 session on Tumor Microenvironment and the complex cross-talk between dysregulated myeloid cells (Leila Akkari Karin de Visser The Netherlands Cancer Institute) and dendritic cells (Boettcher Lab TU München) at single cell and spatial level for #cancer prognosis and #immunotherapy
#CIMT2024 session in Advancing antibodies: Pushing forward technology for #cancer #immunotherapy via BiSpecific Abs (dimitris skokos Regeneron) Hexamerization-enhanced Abs (@estherbreij Genmab BioNTech SE) and BiSpec Abs targeting neutrophils marjolein van egmond Amsterdam UMC
Interesting panel debate on the role of excellent research in Norway and Europe - European Research Council (ERC) visiting Universitetet i Bergen
Now LIVE: the inaugural "Biology and Therapy of Myeloid Malignancies Conference" Fusion Conferences taking place May 14-17, 2025 on a beautiful Minoan coast in Crete, Greece. Huge thanks to co-organizer Ross Levine (and Lee Grimes Lab) ! #MyeloidMalignancies25 fusion-conferences.com/conference/180
New online in Nature Biotechnology by Michal Bassani-Sternberg group: The neoantigen discovery pipeline NeoDisk incorporates mass spectrometry immunopeptidomics data. Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB
New #JITC article: Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire bit.ly/4m8BwmA Johanna Olweus Tom Blankenstein